Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study

Gemcitabine and Platinum-Based Agents for the Prediction of Cancer-Associated Venous Thromboembolism: Results from the Vienna Cancer and Thrombosis Study

Gemcitabine and platinum-based agents could increase the risk of venous thromboembolism (VTE) in patients with cancer. We evaluated the additive predictive utility of these agents towards cancer-associated VTE beyond a recently developed and externally validated clinical prediction model, which was...

Full description

Bibliographic Details
Main Authors: Florian Moik, Nick van Es, Florian Posch, Marcello Di Nisio, Thorsten Fuereder, Matthias Preusser, Ingrid Pabinger, Cihan Ay
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
cancer
venous thromboembolism
chemotherapy
gemcitabine
platinum compounds
Online Access:https://www.mdpi.com/2072-6694/12/9/2493

Internet

https://www.mdpi.com/2072-6694/12/9/2493

Similar Items